Friday 6 November 2026 Export LIVN’s income statement to Excel — free account

LivaNova PLC

LIVN Healthcare Medical Devices

LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.

Revenue: +9.88%
EPS: +27.4%
Free cash flow: −31.0%
Total debt: −31.2%

Quarter to September 2026, against a year earlier

90.67 0.47 −0.52%

Follow LIVN

Alert me

Market cap: $5.0B
P/E: 25.6×
Fwd P/E: 19.8×
Dividend yield: —
F-score: 4/9
Altman Z: 1.74
Beneish M: −3.30
Dividend safety: n/a

Overview

LivaNova PLC (LIVN) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, LivaNova PLC (LIVN) trades at a price to free cash flow of 38.0×. Over the past ten years it has ranged from 0.0× (March 2021) to 571× (June 2021); the current reading is higher than 38% of that period. That is above the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LIVN/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="LivaNova PLC price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LIVN/metrics/price-to-free-cash-flow">LivaNova PLC (LIVN) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	18.9×	0.03%
FY2024	18.9×	(73.79%)
FY2023	72.2×	(1.95%)
FY2022	73.7×	22.69%
FY2021	60.1×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	46.4×	(29.60%)
FY2017	66.0×	36.58%
FY2016	48.3×	—

Period	Price to free cash flow	Change
Sep 2026	31.7×	6.74%
Jun 2026	29.7×	40.92%
Mar 2026	21.1×	11.26%
Dec 2025	18.9×	24.54%
45 more quarters	Free account

Against its own ten years

Low 0.0× High 571×

Ten-year median 48.7×

Current reading's percentile 38

Company	Price to free cash flow
HAE Haemonetics Corporation compare	18.1×
BIO Bio-Rad Laboratories, Inc. compare	30.0×
BRKR Bruker Corporation compare	32.9×
LIVN LivaNova PLC	38.0×
NEOG Neogen Corporation compare	51.0×
ITGR Integer Holdings Corporation compare	53.3×
TXG 10x Genomics compare	63.3×
AXGN AxoGen, Inc. compare	134×
IRTC iRhythm Holdings, Inc. compare	584×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

LivaNova PLC (LIVN) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on LIVN

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on LIVN

Stockrow Weekly